Centogene N.V. Explores Financial Strategies
Company Announcements

Centogene N.V. Explores Financial Strategies

Centogene N.V. (CNTG) has released an update.

Centogene N.V. has amended its loan agreement with Lifera to extend the maturity date and is negotiating potential accounts receivable financing, which is contingent on approval by senior lender Oxford Finance LLC. The firm is also exploring strategic alternatives such as mergers or additional financing, with its current cash reserves projected to last through the second quarter of 2024. Amid these developments, Centogene is delaying its Annual Report on Form 20-F filing, seeking a 15-day extension due to ongoing financial discussions.

For further insights into CNTG stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskCentogene NV Announces Nasdaq Delisting
TheFlyCentogene receives delisting notice from Nasdaq
TheFlyCentogene publishes ROPAD study data on Parkinson’s disease in Brain
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App